Andrew J. Thompson

Andrew J. Thompson's work experience begins in 2001 when they worked as a Postdoctoral Scientist at Ludwig Cancer Research, pioneering innovative chemical applications for protein analysis. In 2004, they joined Proteome Sciences plc as a Postdoctoral Scientist, spearheading an ambitious Alzheimer's disease drug target discovery program. From 2008 to 2009, Thompson served as an MRC Centre Mass Spectrometrist at King's College London, responsible for mass spectrometry projects and promoting the proteomics unit. Starting in 2009, they worked at The Institute of Cancer Research as the Proteomics Facility Manager, establishing a successful biotech unit for science as a service. From 2008 to 2016, Thompson served as an Advisor & Consultant, providing specialist consultation to research teams, biotech firms, and advisory firms. In 2017, they joined Vita Cloud Technology as a Director, advising on company formation and R&D for bioinformatics product development. In 2019, Thompson took on the role of Strategic Development Lead at Jiva.ai Ltd, guiding the implementation of venture development, R&D programs, and fundraising strategies for the AI/ML startup. Additionally, in 2019, they assumed the role of Program Director at Kinomica Limited, providing strategic management and venture development advice for their unique technology suite. Throughout their career, Thompson has demonstrated expertise in strategic development, biotechnology, and healthcare/life science ventures.

Andrew J. Thompson earned a Bachelor's Degree in Chemistry & Biochemistry from the University of Melbourne from 1992 to 1996. Following this, they pursued a Doctor of Philosophy (Ph.D.) in Chemistry from an unspecified institution, completing it from 1997 to 2001. Additionally, they obtained a certification in EMBO Scientific Leadership and Management from hfp consulting, although the specific month and year of obtaining the certification are not provided.